NEW YORK (GenomeWeb) – Fluidigm's second quarter revenues jumped 58 percent year over year, or 32 percent organically, the company reported after the close of the market on Thursday.

For the three months ended June 30, Fluidigm's total revenues increased to $27.6 million from $17.5 million in the year-ago quarter and beat the consensus analysts' estimate of $27.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.